OXFORD VACMEDIX UK LIMITED

Company number 07994205 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£576,653

Balance sheet as at 2016-03-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2012-03-16
Registered office
The Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, United Kingdom, OX4 4GA
Postcode
OX4 4GA
Capital
197 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-11-29
Next due by
2026-12-13
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 10 current · 14 resigned

Sang Hoon PAIK Director
Appointed 2026-05-08
Sung Jun HAN Director
Appointed 2024-07-15
Sang Tae PARK Director
Appointed 2022-02-24
Jae Ho LEE Director
Company Director Appointed 2022-01-21
Appointed 2018-05-04

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZA740691 (Tier 1), registered since 2020.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
oxfordvacmedix.com

With our unique recombinant overlapping peptide platform we aim to make safe, highly efficacious immunotherapies that are HLA unrestricted...

Among its peers

Top 25%

by shareholders' funds, of 180 similar companies in OX

Among the oldest 25% of its local peers, trading since 2012.

69 companies are registered at this postcode →

Competitors Oxford

This company ranks 44 among research and experimental development on biotechnology in Oxford.

Full league table →

The class of 2012

32%

of the 280 companies in this sector incorporated in 2012 are still active today; 66% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →